Conversely, in the univariable analysis, patients with TP53 comutation exhibited significantly poorer PFS (HR, 1.58 [95% CI, 0.99 to 2.52]; P = .048), whereas a trend was observed for OS (HR, 1.53 [95% CI, 0.91 to 2.60]; P = .104), although it did not reach statistical significance.
← all excerpts
Impact of Baseline β-Catenin Comutations on Prognosis in EGFR-Mutant Lung Cancer.
1
—
—